Business Context and Reporting Period
This Form 6-K filing by Diginex Ltd (Diginex) covers the month of March 2026. The report details a corporate action regarding the extension of exercise periods for specific warrants issued to Rhino Ventures Limited (RVL), an entity owned and controlled by the Company's Chairman, Miles Pelham.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the amendment of warrant terms and does not contain financial performance data.
Material Changes
On March 20, 2026, the Board of Directors approved a two-year extension to the exercise periods for four distinct warrant series held by RVL. Mr. Pelham abstained from the vote. The specific changes are:
- Founders Warrant: 4,170,520 warrants exercisable at US$6.13. The exercise period was extended from May 27, 2027, to May 27, 2029.
- IPO Warrant No. 1: 18,000,000 warrants exercisable at $1.03. The exercise period was extended from April 23, 2026, to April 23, 2028.
- IPO Warrant No. 2: 18,000,000 warrants exercisable at $1.28. The exercise period was extended from July 23, 2026, to July 23, 2028.
- IPO Warrant No. 3: 18,000,000 warrants exercisable at $1.54. The exercise period was extended from January 23, 2027, to January 23, 2029.
Outlook, Risks, and Management Commentary
The filing does not contain forward-looking guidance, general management commentary on business outlook, or a discussion of risks and contingencies beyond the specific transaction described. The primary unusual item is the significant extension of warrant maturities for a related party, which alters the potential dilution timeline for existing shareholders.
Investor Verification Checklist
- Verify the total number of shares potentially issuable upon full exercise of the amended warrants (noting the Founders Warrant could result in 51% of outstanding shares).
- Confirm the current market price of Diginex shares relative to the exercise prices ($1.03, $1.28, $1.54, and $6.13) to assess the likelihood of exercise.
- Review the related party transaction disclosures to ensure the extension terms were fair to minority shareholders.
- Check for any subsequent filings regarding the actual exercise of these warrants following the extension.